Safety of propofol use in children and adolescents: A disproportionality analysis of the Food and Drug Administration adverse event reporting system (FAERS)

被引：0
|
作者：
Li, Hailong [1 ]
Bo, Zhenyan [1 ]
Zhang, Lingli [1 ]
机构：
[1] Sichuan Univ, West China Univ Hosp 2, Dept Pharm, Chengdu, Sichuan, Peoples R China
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：334 / 335
页数：2
相关论文
共 50 条
  • [21] A disproportionality analysis of sunitinib in the FDA adverse event reporting system (FAERS)
    Zou, Wenbin
    Yang, Han
    Xi, Yu
    Zeng, Chenxi
    Chen, Wei
    Fu, Xiangning
    HELIYON, 2024, 10 (17)
  • [22] Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System
    Anna Gaimari
    Michele Fusaroli
    Emanuel Raschi
    Elisa Baldin
    Luca Vignatelli
    Francesco Nonino
    Fabrizio De Ponti
    Jessica Mandrioli
    Elisabetta Poluzzi
    Drug Safety, 2022, 45 : 663 - 673
  • [23] Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System
    Gaimari, Anna
    Fusaroli, Michele
    Raschi, Emanuel
    Baldin, Elisa
    Vignatelli, Luca
    Nonino, Francesco
    De Ponti, Fabrizio
    Mandrioli, Jessica
    Poluzzi, Elisabetta
    DRUG SAFETY, 2022, 45 (06) : 663 - 673
  • [24] Cardiovascular safety profile of romosozumab: A pharmacovigilance analysis of the US Food and Drug Administration adverse event reporting system (FAERS)
    Kvist, Annika
    Faruque, Junaid A. Y.
    Burden, Andrea M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 159 - 160
  • [25] Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)
    Kvist, Annika Vestergaard
    Faruque, Junaid
    Vallejo-Yague, Enriqueta
    Weiler, Stefan
    Winter, Elizabeth M.
    Burden, Andrea M.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (08)
  • [26] Analysis of Information on Drug Adverse Reactions Using US Food and Drug Administration Adverse Event Reporting System (FAERS)
    Nango, Daisuke
    Sekizuka, Tuyoshi
    Goto, Makoto
    Echizen, Hirotoshi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2022, 142 (04): : 341 - 344
  • [27] ANAPHYLAXIS ADVERSE EVENTS WITH 3RD GENERATION CEPHALOSPORINS: DISPROPORTIONALITY ANALYSIS OF THE UNITED STATES FOOD AND DRUG ADMINISTRATION ADVERSE EVENT REPORTING SYSTEM (FAERS)
    Pawar, A. M.
    Caffrey, A. R.
    VALUE IN HEALTH, 2014, 17 (03) : A265 - A265
  • [28] Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Moreland-Head, Lindsay N.
    Coons, James C.
    Seybert, Amy L.
    Gray, Matthew P.
    Kane-Gill, Sandra L.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2021, 26 (04) : 341 - 348
  • [29] Hypnotics and infections: disproportionality analysis of the US Food & Drug Administration adverse event reporting system database
    Meng, Long
    Huang, Jing
    He, Qin
    Zhao, Yibei
    Zhao, Wenlong
    Tan, Juntao
    Sun, Shusen
    Yang, Junqing
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2022, 18 (09): : 2229 - 2235
  • [30] Safety Evaluation of the Combination with Dexrazoxane and Anthracyclines: A Disproportionality Analysis Based on the Food and Drug Administration Adverse Event Reporting System Database
    Liu, Danyi
    Liu, Junting
    Xiao, Rui
    Deng, Anqi
    Liu, Wei
    PHARMACEUTICALS, 2024, 17 (12)
12345